| Protocol ID |
|
Title |
|
|
| In house-MRI |
|
Investigation of the Utility of Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning
Keywords: Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning (Brain, Breast, Head & Neck, Lung, Cervix, Sacroma, Prostate, or Liver and Liver Mets) |
|
| E1208 |
|
A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in E1208: Unresectable Hepatocellular Carcinoma (HCC) in Patients with and Without Vascular Invasion
Keywords: Unresectable Hepatocellular Carcinoma (HCC) in Patients with and Without Vascular Invasion |
|
| IIT-RT-SORAFENIB |
|
Phase I study of radiation therapy with concurrent sorafenib for hepatocellular carcinoma not responding to transarterial chemoembolization
Keywords: hepatocellular carcinoma |
|
| ACOSOG Z5041 |
|
A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients with Operable Pancreatic Adenocarcinoma
Keywords: Operable Pancreatic Adenocarcinoma |
|
| In House-database |
|
Hepato-pancreatico-biliary (HPB) Clinical Database
Keywords: HPB clinical database |
|
| In-House-QOL Pancreas |
|
Quality of Life Assessment for Adenocarcinoma of the Pancreatic Head, ampulla, and/or uncinate
Keywords: quality of life assessment |
|
| In-House- tissue bank |
|
Tissue Bank
Keywords: tissue bank |
|
| RTOG0848 |
|
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Keywords: Patients with Resected Head of Pancreas Adenocarcinoma |
|
| Industry-hepatic registry |
|
Hepatic Research Registry
Keywords: hepatic registry |
|
| Industry (Also in GI) |
|
Randomized Comparative Study of FOLFOX 6m Plus Sir-Spheres Microspheres v. FOLFOX 6m Alone as First Line Treatment in Patients with Nonresectable Liver Metastases from Primary Colorectal Carcinoma
Keywords: Nonresectable Liver Metastases from Primary Colorectal Carcinoma |
|
| In-house —Pancreas |
|
Phase II Trial of Molecular Profiling to Guide Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreatic Head, Neck or Uncinate Process
Keywords:Resectable and Borderline Resectable Adenocarcinoma |
|
| In-House Liver |
|
Development of Body MRI Biomarkers
Keywords: Body MRI Biomarkers, Liver |
|
| Industry-HPB |
|
Caris Registry
Keywords: Pancreas, liver, gallbladder registry |
|
| In House-Pancreas |
|
Tissue Donation Program
Keywords: Pacrease Tissue Donation Program |
|
|
| In-house psychosocial |
|
Study Analyzing the Use of the Dialectical Behavior Therapy (DBT) Skills Set and Psychosocial Stress with Cancer Patients
Keywords:Breast, Gyn, GI, GU Dialectical Behavior Therapy (DBT) |
|
| Industry — (also in colon) |
|
A Phase III Clinical Trial Evaluating TheraSphere® in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy
Keywords:Metastatic Colorectal Carcinoma of the Liver |